HCP5 and breast cancer: Interestingly, HCP5 has been reported as a ceRNA with involvement in the development of lymphoma [26], oral squamous cell carcinoma [27], breast cancer [28], laryngeal squamous cell carcinoma [29], and prostate cancer [30].